Affinity DataKi: 1.30nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4.40nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 4.60nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 4.60nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 4.70nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 8.30nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.10nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.20nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 9.40nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 11nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 14nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 16nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 22nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 24nMAssay Description:Compound was evaluated for the inhibition of thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 28nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 33nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 35nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 36nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 36nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 39nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 39nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 40nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 44nMAssay Description:Inhibitory constant against human alpha thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 44nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
Affinity DataKi: 52nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 58nMAssay Description:Inhibition of Human kidney cell urokinaseMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 60nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 60nMAssay Description:In vitro binding affinity towards human Complement C1s subcomponentMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 70nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 70nMAssay Description:In vitro binding affinity towards human Complement C1s subcomponentMore data for this Ligand-Target Pair
Affinity DataKi: 70nMAssay Description:Compound was tested in vitro for its ability to inhibit serine protease thrombin using succinyl-Ala-p-nitroanilide as substrateMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 80nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 90nMAssay Description:In vitro binding affinity towards human Complement C1s subcomponentMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 101nMAssay Description:Inhibition of Human kidney cell urokinaseMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 102nMAssay Description:Inhibition of Human kidney cell urokinaseMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 103nMAssay Description:Inhibition of Human kidney cell urokinaseMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair
Affinity DataKi: 115nMAssay Description:Anti- Thrombin activity using standard chromogenic assayMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 138nMAssay Description:Inhibition of Human kidney cell urokinaseMore data for this Ligand-Target Pair
TargetComplement C1s subcomponent(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 150nMAssay Description:In vitro binding affinity towards human Complement C1s subcomponentMore data for this Ligand-Target Pair
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
3-Dimensional Pharmaceuticals
Curated by ChEMBL
3-Dimensional Pharmaceuticals
Curated by ChEMBL
Affinity DataKi: 160nMAssay Description:In vitro inhibitory activity against Urokinase-type plasminogen activator (microPa)More data for this Ligand-Target Pair